TOLVANEF-15 is a vasopressin V2-receptor antagonist containing Tolvaptan 15 mg. It is used to treat hyponatremia (low blood sodium levels) and to slow the progression of autosomal dominant polycystic kidney disease (ADPKD) in patients with preserved kidney function.
Composition
Tolvaptan – 15 mg
Uses
Treatment of hyponatremia
Slowing progression of ADPKD
Benefits
Helps restore normal sodium levels in the blood
Slows cyst growth in polycystic kidney disease
Supports kidney function preservation
Improves overall patient quality of life
Disclaimer
This information is for educational purposes only and does not replace professional medical advice. Use only under the supervision of a registered healthcare professional.
